Mutations in muscle-type creatine kinase impact HIV prevention.

Abstract excerpt

There is large interindividual variability in the efficacy of pre-exposure prophylaxis (PrEP) with tenofovir (TFV) in preventing HIV infection. Naturally occurring mutations in the creatine kinase M-type (CKM) gene examined by Mosher et al. could provide answers to why some individuals who have active serum creatine kinase in clinical assessments may not respond to TFV PrEP.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Tenofovir
• Share to HIV Infections
• Share to Muscles